By expenditures
| Name | Title | Type |
|---|---|---|
| Ankit Patel | Cfo | Auditee |
| Jason Flahive | Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 371100 | 2024 | 2025-10-21 | OSTROW REISIN BERK & ABRAMS LTD | $6.17M |
| 362703 | 2023 | 2025-07-22 | Ostrow Reisin Berk & Abrams LTD | $8.80M |
| 338769 | 2022 | 2025-01-17 | Ostrow Reisin Berk & Abrams LTD | $9.94M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 371100 | 2024 | 2025-10-21 | 1161104 | 2024-001 | Material Weakness | Yes | L |
| 371100 | 2024 | 2025-10-21 | 1161103 | 2024-001 | Material Weakness | Yes | L |
| 362703 | 2023 | 2025-07-22 | 1148154 | 2023-002 | Significant Deficiency | Yes | L |
| 362703 | 2023 | 2025-07-22 | 1148153 | 2023-002 | Significant Deficiency | Yes | L |
| 362703 | 2023 | 2025-07-22 | 1148152 | 2023-002 | Significant Deficiency | Yes | L |
| 362703 | 2023 | 2025-07-22 | 1148151 | 2023-002 | Significant Deficiency | Yes | L |
| 362703 | 2023 | 2025-07-22 | 571712 | 2023-002 | Significant Deficiency | Yes | L |
| 362703 | 2023 | 2025-07-22 | 571711 | 2023-002 | Significant Deficiency | Yes | L |
| 362703 | 2023 | 2025-07-22 | 571710 | 2023-002 | Significant Deficiency | Yes | L |
| 362703 | 2023 | 2025-07-22 | 571709 | 2023-002 | Significant Deficiency | Yes | L |
| 338769 | 2022 | 2025-01-17 | 1096131 | 2022-002 | Significant Deficiency | - | L |
| 338769 | 2022 | 2025-01-17 | 1096130 | 2022-002 | Significant Deficiency | - | L |
| 338769 | 2022 | 2025-01-17 | 1096129 | 2022-002 | Significant Deficiency | - | L |
| 338769 | 2022 | 2025-01-17 | 1096128 | 2022-002 | Significant Deficiency | - | L |
| 338769 | 2022 | 2025-01-17 | 519689 | 2022-002 | Significant Deficiency | - | L |
| 338769 | 2022 | 2025-01-17 | 519688 | 2022-002 | Significant Deficiency | - | L |
| 338769 | 2022 | 2025-01-17 | 519687 | 2022-002 | Significant Deficiency | - | L |
| 338769 | 2022 | 2025-01-17 | 519686 | 2022-002 | Significant Deficiency | - | L |